133 related articles for article (PubMed ID: 3797547)
1. Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia.
Houston JP; Maas JW; Bowden CL; Contreras SA; McIntyre KL; Javors MA
Psychiatry Res; 1986 Nov; 19(3):207-14. PubMed ID: 3797547
[TBL] [Abstract][Full Text] [Related]
2. Atrophy limited to the third ventricle in chronic schizophrenic patients. Report of a controlled series.
Boronow J; Pickar D; Ninan PT; Roy A; Hommer D; Linnoila M; Paul SM
Arch Gen Psychiatry; 1985 Mar; 42(3):266-71. PubMed ID: 2579616
[TBL] [Abstract][Full Text] [Related]
3. Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid.
Doran AR; Boronow J; Weinberger DR; Wolkowitz OM; Breier A; Pickar D
Neuropsychopharmacology; 1987 Dec; 1(1):25-32. PubMed ID: 3509912
[TBL] [Abstract][Full Text] [Related]
4. Lateral ventricle-brain ratio and balance between CSF HVA and 5-HIAA in schizophrenia.
Lewine RR; Risch SC; Risby E; Stipetic M; Jewart RD; Eccard M; Caudle J; Pollard W
Am J Psychiatry; 1991 Sep; 148(9):1189-94. PubMed ID: 1715677
[TBL] [Abstract][Full Text] [Related]
5. Brain ventricular size and CSF monoamine metabolites in an adolescent inpatient population.
Jennings WS; Schulz SC; Narasimhachari N; Hamer RM; Friedel RO
Psychiatry Res; 1985 Oct; 16(2):87-94. PubMed ID: 2415997
[TBL] [Abstract][Full Text] [Related]
6. Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy.
van Kammen DP; Mann LS; Sternberg DE; Scheinin M; Ninan PT; Marder SR; van Kammen WB; Rieder RO; Linnoila M
Science; 1983 May; 220(4600):974-7. PubMed ID: 6133351
[TBL] [Abstract][Full Text] [Related]
7. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
Rimón R; Roos BE; Kampman R; Hyyppä S; Ranta P; Myllylä V
Ann Clin Res; 1979 Feb; 11(1):25-9. PubMed ID: 453776
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological test performance, brain morphological measures and CSF monoamine metabolites in schizophrenic patients.
Nyman H; Nybäck H; Wiesel FA; Oxenstierna G; Schalling D
Acta Psychiatr Scand; 1986 Sep; 74(3):292-301. PubMed ID: 3788656
[TBL] [Abstract][Full Text] [Related]
9. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) levels in the cerebrospinal fluid from the lateral ventricle of patients with brain tumors].
Majchrzak H; Kmieciak-Kołada K; Felińska W; Herman ZS; Wencel T
Neurol Neurochir Pol; 1986; 20(1):54-8. PubMed ID: 2423908
[TBL] [Abstract][Full Text] [Related]
10. Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy.
van Kammen DP; van Kammen WB; Mann LS; Seppala T; Linnoila M
Arch Gen Psychiatry; 1986 Oct; 43(10):978-83. PubMed ID: 3753162
[TBL] [Abstract][Full Text] [Related]
11. The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients.
Scheepers FE; Gispen-de Wied CC; Westenberg HG; Kahn RS
Neuropsychopharmacology; 2001 Oct; 25(4):468-75. PubMed ID: 11557160
[TBL] [Abstract][Full Text] [Related]
12. Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid.
Degrell I; Nagy E
Biol Psychiatry; 1990 Apr; 27(8):891-6. PubMed ID: 1691925
[TBL] [Abstract][Full Text] [Related]
13. Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history.
Lindström LH
Psychiatry Res; 1985 Apr; 14(4):265-73. PubMed ID: 2410940
[TBL] [Abstract][Full Text] [Related]
14. [Study on dopamine metabolite in cerebrospinal fluid of schizophrenics and epilepsics].
Jiang S; Chen X; Liao W
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):155-6. PubMed ID: 10681831
[TBL] [Abstract][Full Text] [Related]
15. Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVA.
Doran AR; Rubinow DR; Wolkowitz OM; Roy A; Breier A; Pickar D
Biol Psychiatry; 1989 Feb; 25(4):431-9. PubMed ID: 2564787
[TBL] [Abstract][Full Text] [Related]
16. Computed tomographic evidence for generalized sulcal and ventricular enlargement in schizophrenia.
Pfefferbaum A; Zipursky RB; Lim KO; Zatz LM; Stahl SM; Jernigan TL
Arch Gen Psychiatry; 1988 Jul; 45(7):633-40. PubMed ID: 3382323
[TBL] [Abstract][Full Text] [Related]
17. Monoamine acid metabolites in ventricular CSF of patients with brain tumours.
Bareggi SR; Porta M; Collice M; Calderini G; Ferrara M; Morselli PL
Acta Neurochir (Wien); 1976; 35(1-3):161-70. PubMed ID: 961500
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid homovanillic acid in cerebral infarction.
Hachinski V; Shibuya M; Norris JW; Hornykiewicz O
J Neural Transm Suppl; 1978; (14):45-50. PubMed ID: 290739
[TBL] [Abstract][Full Text] [Related]
19. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
[TBL] [Abstract][Full Text] [Related]
20. Quantitative computed tomographic study in schizophrenia: cerebral density and ventricle measures.
Rossi A; Stratta P; D'Albenzio L; Di Michele V; Serio A; Giordano L; Petruzzi C; Casacchia M
Psychol Med; 1989 May; 19(2):337-42. PubMed ID: 2762438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
